Timescales of developmental toxicity impacting on research and needs for intervention
| Autor: | Pal Weihe, Jordi Sunyer, Ruth A. Etzel, Carl F. Cranor, Beate Ritz, Karin Sørig Hougaard, Robert Barouki, Patricia A. Hunt, Jerrold J. Heindel, Morando Soffritti, Gail S. Prins, Philippe Grandjean, Tim S. Nawrot, David Gee, Latifa Abdennebi-Najar |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
Big Data
Epigenomics Time Factors Developmental toxicity Vulnerability Endocrine Disruptors Toxicology Ecotoxicology 030226 pharmacology & pharmacy Epigenesis Genetic Fetal Development 0302 clinical medicine Computational Chemistry Pregnancy Medicine Pharmacology & Pharmacy education.field_of_study Pharmacology and Pharmaceutical Sciences General Medicine Environmental exposure Human development (humanity) Risk analysis (engineering) Research Design Prenatal Exposure Delayed Effects Female Patient Safety medicine.medical_specialty Population Risk Assessment Article Environmental Medicine 03 medical and health sciences Genetic Intervention (counseling) Animals Humans Metabolomics education Pharmacology Animal business.industry Prevention Public health Environmental Exposure Congresses as Topic Disease Models Animal Harm Disease Models Generic health relevance business 030217 neurology & neurosurgery Epigenesis |
| Zdroj: | Basic & clinical pharmacology & toxicology, vol 125 Suppl 3, iss Suppl 3 Grandjean, P, Abdennebi-Najar, L, Barouki, R, Cranor, C F, Etzel, R A, Gee, D, Heindel, J J, Hougaard, K S, Hunt, P, Nawrot, T S, Prins, G S, Ritz, B, Soffritti, M, Sunyer, J & Weihe, P 2019, ' Time scales of developmental toxicity impacting on research and needs for intervention ', Basic & Clinical Pharmacology & Toxicology, vol. 125, no. Suppl. 3, pp. 70-80 . https://doi.org/10.1111/bcpt.13162 |
| Popis: | Much progress has happened in understanding developmental vulnerability to preventable environmental hazards. Along with the improved insight, the perspective has widened, and developmental toxicity now involves latent effects that can result in delayed adverse effects in adults or at old age and additional effects that can be transgenerationally transferred to future generations. Although epidemiology and toxicology to an increasing degree are exploring the adverse effects from developmental exposures in human beings, the improved documentation has resulted in little progress in protection, and few environmental chemicals are currently regulated to protect against developmental toxicity, whether it be neurotoxicity, endocrine disruption or other adverse outcome. The desire to obtain a high degree of certainty and verification of the evidence used for decision-making must be weighed against the costs and necessary duration of research, as well as the long-term costs to human health because of delayed protection of vulnerable early-life stages of human development and, possibly, future generations. Although two-generation toxicology tests may be useful for initial test purposes, other rapidly emerging tools need to be seriously considered from computational chemistry and metabolomics to CLARITY-BPA-type designs, big data and population record linkage approaches that will allow efficient generation of new insight; epigenetic mechanisms may necessitate a set of additional regulatory tests to reveal such effects. As reflected by the Prenatal Programming and Toxicity (PPTOX) VI conference, the current scientific understanding and the timescales involved require an intensified approach to protect against preventable adverse health effects that can harm the next generation and generations to come. While further research is needed, the main emphasis should be on research translation and timely public health intervention to avoid serious, irreversible and perhaps transgenerational harm. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|